Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Replimune Group Inc (REPL)

Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Replimune Group Inc 500 Unicorn Park Drive 3rd Floor WOBURN MA 01801 USA

www.replimune.com P: 781-222-9600

Description:

Replimune Group, Inc. is a clinical-stage biotechnology company. It discovers, develops and commercializes oncolytic immunotherapy for the treatment of cancer diseases. The company's product pipeline consists of RP1, RP2 & RP3 which are in clinical stage. Replimune Group, Inc. is based in MA, United States.

Key Statistics

Overview:

Market Capitalization, $K 377,536
Enterprise Value, $K 259,596
Shares Outstanding, K 61,388
Annual Sales, $ 0 K
Annual Net Income, $ -174,280 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -51,120 K
EBIT, $ -229,020 K
EBITDA, $ -232,210 K
60-Month Beta 1.21
% of Insider Shareholders 20.60%
% of Institutional Shareholders 92.53%
Float, K 48,742
% Float 79.40%
Short Volume Ratio 0.65

Growth:

1-Year Return -62.75%
3-Year Return -83.19%
5-Year Return -61.63%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.77 on 02/08/24
Latest Earnings Date 05/16/24
Earnings Per Share ttm -3.16
EPS Growth vs. Prev Qtr 14.44%
EPS Growth vs. Prev Year -11.59%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

REPL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -42.94%
Return-on-Assets % -35.80%
Profit Margin % 0.00%
Debt/Equity 0.11
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.90
Book Value/Share 7.14
Interest Coverage -40.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar